Gut microbiome may shape response to GLP-1 drugs, new review suggests +++++

Gut microbiome may shape response to GLP-1 drugs, new review suggests https://www.news-medical.net/news/20260219/Gut-microbiome-may-shape-response-to-GLP-1-drugs-new-review-suggests.aspx?utm_source=news_medical_newsletter&utm_medium=email&utm_campaign=bowel_cancer_newsletter_24_february_2026 Gut microbiome may shape response to GLP-1 drugs, new review suggestsThis review examines how GLP-1 receptor agonists and the gut microbiome influence one another through bile acid signaling, short-chain fatty acids, and inflammatory pathways. It explores how microbial composition may shape treatment response and highlights the need for controlled human studies to enable microbiome-informed precision therapy. AI tool can accurately predict colorectal cancer risk in UC-LGD patients https://www.news-medical.net/news/20260217/AI-tool-can-accurately-predict-colorectal-cancer-risk-in-UC-LGD-patients.aspx?utm_source=news_medical_newsletter&utm_medium=email&utm_campaign=bowel_cancer_newsletter_24_february_2026 AI tool can accurately predict colorectal cancer risk in UC-LGD patientsPeople with ulcerative colitis (UC), a chronic inflammatory bowel disease, are up to four times more likely to develop colorectal cancer than the general population. Developmental ANGPTL4 deficiency protects mice from colitis and tumors https://www.news-medical.net/news/20260218/Developmental-ANGPTL4-deficiency-protects-mice-from-colitis-and-tumors.aspx?utm_source=news_medical_newsletter&utm_medium=email&utm_campaign=bowel_cancer_newsletter_24_february_2026 Developmental ANGPTL4 deficiency protects mice from colitis and tumorsA novel study using a mouse model has found that the absence of the angiopoietin-like 4 (ANGPTL4) protein during development triggers a long-lasting reprogramming of the immune system that protects against intestinal inflammation. Distinct gut toxicity patterns emerge with targeted cancer treatments https://www.news-medical.net/news/20260220/Distinct-gut-toxicity-patterns-emerge-with-targeted-cancer-treatments.aspx?utm_source=news_medical_newsletter&utm_medium=email&utm_campaign=bowel_cancer_newsletter_24_february_2026 A new paper was published in Volume 13 of Oncoscience on February 6, 2026, titled "Gastrointestinal toxicity of targeted cancer therapies in the United States: Clinicopathologic patterns, FDA safety frameworks, and implications for national patient protection." Study reveals bacterial duo driving chronic constipation https://www.news-medical.net/news/20260219/Study-reveals-bacterial-duo-driving-chronic-constipation.aspx?utm_source=news_medical_newsletter&utm_medium=email&utm_campaign=bowel_cancer_newsletter_24_february_2026 Scientists at Nagoya University in Japan have found two gut bacteria working together that contribute to chronic constipation.